• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随着帕金森病的进展,纹状体多巴胺能神经元会丧失。

Striatal dopaminergic neurons are lost with Parkinson's disease progression.

作者信息

Porritt Michelle J, Kingsbury Ann E, Hughes Andrew J, Howells David W

机构信息

Austin Health, Department of Medicine, University of Melbourne, Victoria, Australia.

出版信息

Mov Disord. 2006 Dec;21(12):2208-11. doi: 10.1002/mds.21129.

DOI:10.1002/mds.21129
PMID:17029264
Abstract

Increased numbers of dopaminergic neurons are described in the striatum of patients with Parkinson's disease. In postmortem striatal tissue from Parkinson's disease patients with short disease duration (< or =8 years), the number of dopaminergic neurons is approximately four times that in patients with long duration (> or =16 years). The data suggest the possibility that the presence of large numbers of these striatal dopaminergic neurons may be harmful and may accelerate the disease process. Alternatively, these neurons may be lost to the disease process.

摘要

帕金森病患者纹状体中多巴胺能神经元数量增加。在病程较短(≤8年)的帕金森病患者的死后纹状体组织中,多巴胺能神经元数量约为病程较长(≥16年)患者的四倍。这些数据表明,大量这些纹状体多巴胺能神经元的存在可能有害,并可能加速疾病进程。或者,这些神经元可能在疾病过程中丢失。

相似文献

1
Striatal dopaminergic neurons are lost with Parkinson's disease progression.随着帕金森病的进展,纹状体多巴胺能神经元会丧失。
Mov Disord. 2006 Dec;21(12):2208-11. doi: 10.1002/mds.21129.
2
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中纹状体多巴胺能神经元的命运。
Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2.
3
Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.帕金森病中脑特定的A10多巴胺能核会发生退化。
Exp Neurol. 1997 Mar;144(1):202-13. doi: 10.1006/exnr.1997.6418.
4
Dopaminergic responses to striatal damage.对纹状体损伤的多巴胺能反应。
J Neurol Sci. 1996 Jul;139(1):125-30.
5
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.在帕金森病大鼠模型中,分子氢对6-羟基多巴胺诱导的黑质纹状体变性具有保护作用。
Neurosci Lett. 2009 Apr 3;453(2):81-5. doi: 10.1016/j.neulet.2009.02.016. Epub 2009 Feb 12.
6
Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.帕金森病大鼠模型黑质纹状体多巴胺耗竭后外周免疫参数的时间依赖性变化
Brain Behav Immun. 2009 May;23(4):518-26. doi: 10.1016/j.bbi.2009.01.018. Epub 2009 Feb 7.
7
Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.在帕金森病的神经移植策略中,非离子表面活性剂泊洛沙姆188的辅助使用可提高胎儿多巴胺能细胞的存活率和再支配能力。
Eur J Neurosci. 2008 Jan;27(1):43-52. doi: 10.1111/j.1460-9568.2007.05991.x. Epub 2007 Dec 15.
8
Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)处理的SAMP8小鼠黑质纹状体系统的损伤
Neurosci Lett. 2008 Dec 26;448(2):184-8. doi: 10.1016/j.neulet.2008.10.070. Epub 2008 Oct 25.
9
Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.移植的5-羟色胺能和多巴胺能神经元对帕金森病大鼠左旋多巴诱导的运动障碍发展的影响取决于多巴胺能神经元变性的程度。
Brain. 2009 Feb;132(Pt 2):319-35. doi: 10.1093/brain/awn305. Epub 2008 Nov 27.
10
New dopaminergic neurons in Parkinson's disease striatum.帕金森病纹状体中的新生多巴胺能神经元。
Lancet. 2000 Jul 1;356(9223):44-5. doi: 10.1016/S0140-6736(00)02437-5.

引用本文的文献

1
Evolutionary innovations in the primate dopaminergic system.灵长类动物多巴胺能系统的进化创新。
Curr Opin Genet Dev. 2024 Oct;88:102236. doi: 10.1016/j.gde.2024.102236. Epub 2024 Aug 16.
2
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson's Disease.用于治疗帕金森病的新型双NRF2诱导剂和选择性单胺氧化酶B抑制剂系列
Antioxidants (Basel). 2022 Jan 27;11(2):247. doi: 10.3390/antiox11020247.
3
The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
帕金森病中α-突触核蛋白的朊样传播:模型和假说的更新。
Int J Mol Sci. 2021 Aug 3;22(15):8338. doi: 10.3390/ijms22158338.
4
Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.丘脑底核脑深部电刺激与左旋多巴治疗帕金森病:联合作用的荟萃分析。
J Neurol. 2019 Feb;266(2):289-297. doi: 10.1007/s00415-018-8936-2. Epub 2018 Jun 16.
5
Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway.黑质纹状体多巴胺能通路丧失后纹状体TH中间神经元的解剖学和电生理学变化。
Brain Struct Funct. 2015 Jan;220(1):331-49. doi: 10.1007/s00429-013-0658-8. Epub 2013 Oct 31.
6
Heterogeneity and diversity of striatal GABAergic interneurons.纹状体 GABA 能中间神经元的异质性和多样性。
Front Neuroanat. 2010 Dec 29;4:150. doi: 10.3389/fnana.2010.00150. eCollection 2010.
7
Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum.成年小鼠纹状体中表达酪氨酸羟化酶的神经元的电生理和形态特征及突触连接。
J Neurosci. 2010 May 19;30(20):6999-7016. doi: 10.1523/JNEUROSCI.5996-09.2010.